Wang W, Wang X
Front Psychiatry. 2025; 16:1431839.
PMID: 40051769
PMC: 11882862.
DOI: 10.3389/fpsyt.2025.1431839.
Anke T, Skjelstad D
Int J Bipolar Disord. 2025; 13(1):9.
PMID: 39992465
PMC: 11850689.
DOI: 10.1186/s40345-025-00374-x.
Montanari S, Jansen R, Schranner D, Kastenmuller G, Arnold M, Janiri D
Transl Psychiatry. 2025; 15(1):65.
PMID: 39988721
PMC: 11847943.
DOI: 10.1038/s41398-025-03274-x.
Singh A, Bekhbat M, Goldsmith D, Le N, Wommack E, Li Z
Compr Psychoneuroendocrinol. 2025; 21:100284.
PMID: 39981264
PMC: 11840189.
DOI: 10.1016/j.cpnec.2025.100284.
Schramm E, Elsaesser M, Muller J, Kwarteng N, Evrenoglou T, Cuijpers P
BMJ Open. 2025; 15(2):e089356.
PMID: 39971604
PMC: 11840898.
DOI: 10.1136/bmjopen-2024-089356.
Predicting incident cardio-metabolic disease among persons with and without depressive and anxiety disorders: a machine learning approach.
Rydin A, Aalbers G, van Eeden W, Lamers F, Milaneschi Y, Penninx B
Soc Psychiatry Psychiatr Epidemiol. 2025; .
PMID: 39966164
DOI: 10.1007/s00127-025-02857-9.
Basolateral amygdala volume in affective disorders using 7T MRI .
Kurzinger B, Schindler S, Meffert M, Rosenhahn A, Trampel R, Turner R
Front Psychiatry. 2025; 15():1404594.
PMID: 39834577
PMC: 11744004.
DOI: 10.3389/fpsyt.2024.1404594.
Increased Herpes simplex virus 1, Toxoplasma gondii and Cytomegalovirus antibody concentrations in severe mental illness.
Andreou D, Steen N, Jorgensen K, Ueland T, Wortinger L, Morch-Johnsen L
Transl Psychiatry. 2024; 14(1):498.
PMID: 39695093
PMC: 11655861.
DOI: 10.1038/s41398-024-03198-y.
Sustained effects of repeated levodopa (L-DOPA) administration on reward circuitry, effort-based motivation, and anhedonia in depressed patients with higher inflammation.
Mandakh B, Bekhbat M, Zhihao L, Li Z, Dunlop B, Treadway M
Brain Behav Immun. 2024; 125:240-248.
PMID: 39694342
PMC: 11903141.
DOI: 10.1016/j.bbi.2024.12.026.
Fractal motor activity during wakefulness and sleep: a window into depression recency and symptom recurrence.
Minaeva O, Riese H, Booij S, Lamers F, Giltay E, Scheer F
Psychol Med. 2024; :1-9.
PMID: 39620467
PMC: 11650180.
DOI: 10.1017/S0033291724002769.
A computational signature of self-other mergence in Borderline Personality Disorder.
Story G, Ereira S, Valle S, Chamberlain S, Grant J, Dolan R
Transl Psychiatry. 2024; 14(1):473.
PMID: 39562590
PMC: 11576885.
DOI: 10.1038/s41398-024-03170-w.
Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression: A protocol for systematic review and meta-analysis.
Rodrigues M, Junkes L, Appolinario J, Nardi A
PLoS One. 2024; 19(10):e0306227.
PMID: 39405311
PMC: 11478908.
DOI: 10.1371/journal.pone.0306227.
Efficacy of inflammation-based stratification for add-on celecoxib or minocycline in major depressive disorder: Protocol of the INSTA-MD double-blind placebo-controlled randomised clinical trial.
Wessa C, Janssens J, Coppens V, El Abdellati K, Vergaelen E, van den Ameele S
Brain Behav Immun Health. 2024; 41:100871.
PMID: 39350954
PMC: 11440344.
DOI: 10.1016/j.bbih.2024.100871.
Digital Platform for the Prevention of Suicidal Behaviour and Non-Suicidal Self-Injuries in Adolescents: The SmartCrisis-Teen Study Protocol.
Abascal-Peiro S, Penuelas-Calvo I, Alacreu-Crespo A, Saiz P, de la Torre-Luque A, Ruiz-Veguilla M
Behav Sci (Basel). 2024; 14(9).
PMID: 39335956
PMC: 11428467.
DOI: 10.3390/bs14090740.
Hippocampal, thalamic, and amygdala subfield morphology in major depressive disorder: an ultra-high resolution MRI study at 7-Tesla.
Liu W, Heij J, Liu S, Liebrand L, Caan M, van der Zwaag W
Eur Arch Psychiatry Clin Neurosci. 2024; .
PMID: 39217211
DOI: 10.1007/s00406-024-01874-0.
Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial.
Ohtani Y, Tani H, Nomoto-Takahashi K, Yatomi T, Yonezawa K, Tomiyama S
Psychiatry Clin Neurosci. 2024; 78(12):765-775.
PMID: 39210712
PMC: 11612546.
DOI: 10.1111/pcn.13734.
Psychometric Evaluation of the Insomnia Severity Index in U.S. College Students.
Emert S, Dietch J, Bramoweth A, Kelly K, Taylor D
Behav Ther. 2024; 55(5):990-1003.
PMID: 39174275
PMC: 11341948.
DOI: 10.1016/j.beth.2024.02.003.
Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort.
Milaneschi Y, Montanari S, Jansen R, Schranner D, Kastenmuller G, Arnold M
Res Sq. 2024; .
PMID: 39149483
PMC: 11326352.
DOI: 10.21203/rs.3.rs-4638158/v1.
Fetal behavior and gestational serotonin reuptake inhibitor exposure: relationships between behavior, drug dosage, plasma drug level, and a measure of drug bioeffect.
Salisbury A, Anderson G, Yang A, Stika C, Rasmussen-Torvik L, Gollan J
Neuropsychopharmacology. 2024; 49(13):1968-1977.
PMID: 39127823
PMC: 11480508.
DOI: 10.1038/s41386-024-01923-1.
Cognitive Symptoms Are Not Associated with Cognitive Performance in Post-Acute mTBI.
Levy A, Saling M, Anderson J
Arch Clin Neuropsychol. 2024; 40(1):63-74.
PMID: 39110919
PMC: 11754668.
DOI: 10.1093/arclin/acae060.